Intestinal strontium absorption is becoming accepted as a clinical and diagnostic tool for assessing intestinal calcium absorption in humans. However, little is known about whether intestinal strontium absorption, like that of calcium, is stimulated by calcitriol in healthy humans. Methods: The effect of calcitriol on intestinal strontium absorption was measured in eight healthy men, ages 20 -60 years. Before administration of calcitriol, two tests were performed with an interval of 10 days for calculating the within-subject variation (SE R ). Before the third test, 0.5 g of calcitriol was given twice daily for 3 days. In each test, the fractional strontium absorption (Fc 240 ) and the area under the concentration-time curve (AUC 0 -240 ) 4 h after an oral strontium load of 2.5 mmol were calculated. Results: The within-subject SE R of Fc 240 and AUC
and its sensitivity to calcitriol were better than those of Fc 240 , the Fc 240 of strontium is preferred for a clinical test because of its simplicity, requiring only two instead of five blood samples.
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Abnormal or inadequate intestinal calcium absorption is a contributing factor in certain disease states, e.g., osteoporosis. The study of intestinal calcium absorption and calcium metabolism in animals and humans is essential for further elucidating basic mechanisms, for understanding disease processes, and for assessing therapeutic strategies.
Strontium has become a clinical and diagnostic tool for measuring calcium absorption in humans (1) (2) (3) (4) (5) (6) . Various studies have demonstrated a close correlation between the intestinal absorption of (radioactive) calcium and nonradioactive strontium (7, 8 ) . Previously, we determined the bioavailability (AUC po ϱ /AUC iv ϱ ϫ Dose iv /Dose po ) of SrCl 2 in healthy male volunteers to obtain a simple parameter that is most representative for intestinal absorption. We found that the bioavailability of SrCl 2 correlated best with the fractional absorption of strontium at 240 min (Fc 240 ) 3 after the oral intake of the test solution (1 ) . Using this test, we undertook a double-blind placebo-controlled study to investigate whether 17␤-estradiol stimulates intestinal strontium absorption in healthy postmenopausal women (9 ) . In that study, 17␤-estradiol did not affect the Fc 240 of strontium after the test solution was ingested. A possible explanation could be that the calcium/strontium load (9.0 mmol of calcium and 5.0 mmol of strontium) given to the women was too high, which could render the test insensitive with respect to the possible stimulation of active transport by 17␤-estradiol. Therefore, we reduced the load of the test to 2.5 mmol of strontium only.
The aim of this study was to assess the reproducibility of the renewed strontium absorption test. Thereafter, the stimulatory effect of calcitriol [1,25(OH) 2 D 3 ] on intestinal strontium absorption, as reflected by Fc 240 , was investigated. To check for possible shifts in the absorption profile, plasma strontium concentrations at 1, 2, and 3 h were also determined.
Materials and Methods study population
Eight healthy male volunteers, ages 20 -60 years, participated in this study. All subjects gave informed consent to participate in the study. The ethics committee of our hospital approved the study. All procedures followed were in accordance with the Declaration of Helsinki. 
data analysis
For each subject, three plasma strontium concentrationtime curves were obtained. All concentrations measured were corrected for endogenous strontium concentrations, determined at t ϭ 0 of each test. The time at which the highest plasma concentration (c max ) was observed was designated t max . The area under the concentration-time curve up to time t (AUC 0 -t ), expressed as mmol ⅐ L Ϫ1 ⅐ min, was calculated by the trapezoidal rule, using the pharmacokinetic computer program Topfit 2.0 (11 ). The Fc of strontium 4 h after an oral strontium load (Fc 240 ) was calculated according to the following formula (1 ):
in which c 240 is the plasma concentration 4 h after ingestion (mmol/L); c 0 is the plasma concentration at 0 min (mmol/L); V is the central volume of distribution, represented by 15% of the body weight (L); and D is the dose of strontium (2.5 mmol).
The within-subject variation of Fc 240 was determined from its values in test 1 (baseline, x i1 ) and test 2 (replicated test, x i2 ) by the equation:
in which n represents the number of volunteers (n ϭ 8).
statistical analysis
Data are expressed as the mean (Ϯ SE). Between-and within-subject variations were assessed for Fc 240 and AUC 0 -240 . The significance of the stimulatory effect of 
Results
The plasma concentration-time curves of strontium at baseline and after 1,25(OH) 2 D 3 treatment of each subject are shown in Fig. 1 . After oral administration of the test solution, the mean maximum plasma strontium concentration of the baseline test was 51.9 Ϯ 5.0 mol/L (range, 25.4 -69.3 mol/L; n ϭ 8). This maximum concentration (c max ) was reached at a mean time (t max ) of 173 min (range, 120 -240 min) after administration.
The within-and between-subject variation of Fc 240 and AUC 0 -240 are shown in Table 1 . The within-subject variation (SE R ) of the AUC 0 -240 was approximately twofold lower than that of the Fc 240 (0.83 Ϯ 0.1 and 1.7 Ϯ 0.7, respectively).
The biochemical variables (Table 2) did not show a significant change after treatment with 0. Fig. 1 illustrates that under the influence of 1,25(OH) 2 D 3 , the mean value of c max increased to 74 Ϯ 7.6 mol/L (range, 51.2-114.1 mol/L; n ϭ 8) and the mean value of t max decreased to 128 min (range, 60 -240 min).
Discussion
As expected (12 ) , reducing the load of the strontium absorption test to 2.5 mmol of strontium only, instead of 9.0 mmol of calcium and 5.0 mmol of strontium (1 ), produced an increased value of Fc 240 , i.e., from 7.0% to 21.8%. The within-subject variation for Fc 240 of strontium was considerably better than that described earlier (1, 7 ) . Furthermore, the CV for AUC 0 -240 was 10%, which is quite similar to the CV of 11.8% reported by Vezzoli et al. The stimulating effect of 1,25(OH) 2 D 3 on intestinal calcium absorption has already been well established (13, 14 ) . With regard to strontium, different opinions exist about the mechanism of strontium transport through the intestinal wall. Dumont et al. (15 ) have concluded from their experiments that transport of strontium is passive only. Others have found evidence for active intestinal strontium absorption and indications for a common transport mechanism of calcium and strontium (16, 17 ) . Our previous studies in rats gave evidence for active transport of strontium across the intestinal wall, which was 1,25(OH) 2 D 3 dependent (18 ). To apply strontium as a marker for intestinal calcium absorption in humans, it is necessary that the effect of intervention on intestinal calcium absorption is reflected by the strontium absorption test.
1,25(OH) 2 D 3 stimulated intestinal strontium absorption by increasing the c max , as illustrated in Fig. 1 ; t max also decreased. This means that strontium, like calcium, is at least partially absorbed by active transport. To date, only one study in humans has discussed the stimulatory effect of 1,25(OH) 2 D 3 on intestinal strontium absorption (19 ) . However, the authors determined fractional strontium absorption by means of deconvolution, for which purpose 45 Ca was given orally and 85 Sr was administered intrave- Heaney (20 ) .
The Fc 240 can be used for the assessment of intestinal strontium absorption after limited sampling. Fc 240 did not correlate with plasma 1,25(OH) 2 D concentrations. A possible explanation for this finding is that the t max is not always near 240 min. Nevertheless, the Fc 240 of strontium was still highly significantly increased after 1,25(OH) 2 D 3 treatment. Therefore, the Fc 240 of strontium can still be used as a measure for intestinal calcium absorption. However, when more information is desired about possible changes in the absorption profile, the concentrationtime curve of strontium must be considered. Under these circumstances, quantitative information can then be obtained by the measurement of an absorption parameter that is based on more than two samples, e.g., AUC 0 -240 . The present study supports the view that the strontium absorption test is a good measure for intestinal calcium absorption. Although the reproducibility of the AUC 0 -240 and its sensitivity to 1,25(OH) 2 D 3 were better than those of Fc 240 , the Fc 240 of strontium is preferred as a clinical test because of its simplicity, requiring only two instead of five blood samples. 
